These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 26441240)

  • 21. Osteoclast regulation of osteoblasts via RANK‑RANKL reverse signal transduction in vitro.
    Zhang S; Wang X; Li G; Chong Y; Zhang J; Guo X; Li B; Bi Z
    Mol Med Rep; 2017 Oct; 16(4):3994-4000. PubMed ID: 28731168
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Secreted frizzled-related protein-1 inhibits RANKL-dependent osteoclast formation.
    Häusler KD; Horwood NJ; Chuman Y; Fisher JL; Ellis J; Martin TJ; Rubin JS; Gillespie MT
    J Bone Miner Res; 2004 Nov; 19(11):1873-81. PubMed ID: 15476588
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Estrogens antagonize RUNX2-mediated osteoblast-driven osteoclastogenesis through regulating RANKL membrane association.
    Martin A; Xiong J; Koromila T; Ji JS; Chang S; Song YS; Miller JL; Han CY; Kostenuik P; Krum SA; Chimge NO; Gabet Y; Frenkel B
    Bone; 2015 Jun; 75():96-104. PubMed ID: 25701138
    [TBL] [Abstract][Full Text] [Related]  

  • 24. LIGHT/TNFSF14 regulates estrogen deficiency-induced bone loss.
    Brunetti G; Storlino G; Oranger A; Colaianni G; Faienza MF; Ingravallo G; Di Comite M; Reseland JE; Celi M; Tarantino U; Passeri G; Ware CF; Grano M; Colucci S
    J Pathol; 2020 Apr; 250(4):440-451. PubMed ID: 31990039
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IL-6 is not required for parathyroid hormone stimulation of RANKL expression, osteoclast formation, and bone loss in mice.
    O'Brien CA; Jilka RL; Fu Q; Stewart S; Weinstein RS; Manolagas SC
    Am J Physiol Endocrinol Metab; 2005 Nov; 289(5):E784-93. PubMed ID: 15956054
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The p38α MAPK positively regulates osteoblast function and postnatal bone acquisition.
    Thouverey C; Caverzasio J
    Cell Mol Life Sci; 2012 Sep; 69(18):3115-25. PubMed ID: 22527716
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Osteoblast-specific overexpression of complement receptor C5aR1 impairs fracture healing.
    Bergdolt S; Kovtun A; Hägele Y; Liedert A; Schinke T; Amling M; Huber-Lang M; Ignatius A
    PLoS One; 2017; 12(6):e0179512. PubMed ID: 28614388
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Novel, Direct NO Donor Regulates Osteoblast and Osteoclast Functions and Increases Bone Mass in Ovariectomized Mice.
    Kalyanaraman H; Ramdani G; Joshua J; Schall N; Boss GR; Cory E; Sah RL; Casteel DE; Pilz RB
    J Bone Miner Res; 2017 Jan; 32(1):46-59. PubMed ID: 27391172
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Knocking down dickkopf-1 alleviates estrogen deficiency induction of bone loss. A histomorphological study in ovariectomized rats.
    Wang FS; Ko JY; Lin CL; Wu HL; Ke HJ; Tai PJ
    Bone; 2007 Feb; 40(2):485-92. PubMed ID: 17055793
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prolactin directly enhances bone turnover by raising osteoblast-expressed receptor activator of nuclear factor kappaB ligand/osteoprotegerin ratio.
    Seriwatanachai D; Thongchote K; Charoenphandhu N; Pandaranandaka J; Tudpor K; Teerapornpuntakit J; Suthiphongchai T; Krishnamra N
    Bone; 2008 Mar; 42(3):535-46. PubMed ID: 18166509
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DLK1 is a novel regulator of bone mass that mediates estrogen deficiency-induced bone loss in mice.
    Abdallah BM; Ditzel N; Mahmood A; Isa A; Traustadottir GA; Schilling AF; Ruiz-Hidalgo MJ; Laborda J; Amling M; Kassem M
    J Bone Miner Res; 2011 Jul; 26(7):1457-71. PubMed ID: 21308776
    [TBL] [Abstract][Full Text] [Related]  

  • 32. α₂-Antiplasmin is involved in bone loss induced by ovariectomy in mice.
    Shiomi A; Kawao N; Yano M; Okada K; Tamura Y; Okumoto K; Matsuo O; Akagi M; Kaji H
    Bone; 2015 Oct; 79():233-41. PubMed ID: 26094563
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ovariectomy-induced bone loss in
    Zhu S; He H; Gao C; Luo G; Xie Y; Wang H; Tian L; Chen X; Yu X; He C
    J Mol Endocrinol; 2018 Apr; 60(3):185-198. PubMed ID: 29339399
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Harmine, a β-carboline alkaloid, inhibits osteoclast differentiation and bone resorption in vitro and in vivo.
    Yonezawa T; Hasegawa S; Asai M; Ninomiya T; Sasaki T; Cha BY; Teruya T; Ozawa H; Yagasaki K; Nagai K; Woo JT
    Eur J Pharmacol; 2011 Jan; 650(2-3):511-8. PubMed ID: 21047508
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IL-1 plays an important role in the bone metabolism under physiological conditions.
    Lee YM; Fujikado N; Manaka H; Yasuda H; Iwakura Y
    Int Immunol; 2010 Oct; 22(10):805-16. PubMed ID: 20679512
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heparin enhances osteoclastic bone resorption by inhibiting osteoprotegerin activity.
    Irie A; Takami M; Kubo H; Sekino-Suzuki N; Kasahara K; Sanai Y
    Bone; 2007 Aug; 41(2):165-74. PubMed ID: 17560185
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The mammalian lectin galectin-8 induces RANKL expression, osteoclastogenesis, and bone mass reduction in mice.
    Vinik Y; Shatz-Azoulay H; Vivanti A; Hever N; Levy Y; Karmona R; Brumfeld V; Baraghithy S; Attar-Lamdar M; Boura-Halfon S; Bab I; Zick Y
    Elife; 2015 May; 4():e05914. PubMed ID: 25955862
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting of the osteoclastogenic RANKL-RANK axis prevents osteoporotic bone loss and soft tissue calcification in coxsackievirus B3-infected mice.
    Lee K; Kim H; Park HS; Kim KJ; Song H; Shin HI; Kim HS; Seo D; Kook H; Ko JH; Jeong D
    J Immunol; 2013 Feb; 190(4):1623-30. PubMed ID: 23303667
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Maslinic acid suppresses osteoclastogenesis and prevents ovariectomy-induced bone loss by regulating RANKL-mediated NF-κB and MAPK signaling pathways.
    Li C; Yang Z; Li Z; Ma Y; Zhang L; Zheng C; Qiu W; Wu X; Wang X; Li H; Tang J; Qian M; Li D; Wang P; Luo J; Liu M
    J Bone Miner Res; 2011 Mar; 26(3):644-56. PubMed ID: 20814972
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anabolic and Antiresorptive Modulation of Bone Homeostasis by the Epigenetic Modulator Sulforaphane, a Naturally Occurring Isothiocyanate.
    Thaler R; Maurizi A; Roschger P; Sturmlechner I; Khani F; Spitzer S; Rumpler M; Zwerina J; Karlic H; Dudakovic A; Klaushofer K; Teti A; Rucci N; Varga F; van Wijnen AJ
    J Biol Chem; 2016 Mar; 291(13):6754-71. PubMed ID: 26757819
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.